Original Research
Accepted on 03 Feb 2026
Long-Term Qipian® Administration Confers Resistance to Airway Inflammation in OVA-Induced Asthmatic Mice
in Asthma
Original Research
Accepted on 03 Feb 2026
in Asthma
Editorial
Accepted on 03 Feb 2026
in Forest Growth
Original Research
Accepted on 03 Feb 2026
in Brain Disease Mechanisms
Original Research
Accepted on 03 Feb 2026
in Inflammation Pharmacology
Original Research
Accepted on 03 Feb 2026
in Inflammation
Original Research
Accepted on 03 Feb 2026
in Social Pediatrics
Review
Accepted on 03 Feb 2026
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 03 Feb 2026
in Geoinformatics
Original Research
Accepted on 03 Feb 2026
in Economic Geology
Review
Accepted on 03 Feb 2026
in Multi-Robot Systems
Mini Review
Accepted on 03 Feb 2026
in Virtual Reality and Human Behaviour
Original Research
Accepted on 03 Feb 2026
in Radiation Oncology
Original Research
Accepted on 03 Feb 2026
in Nutrition and Metabolism
Case Report
Accepted on 03 Feb 2026
in Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders
Original Research
Accepted on 03 Feb 2026
in Multiple Sclerosis and Neuroimmunology
Original Research
Accepted on 03 Feb 2026
in Mucosal Immunity